CD44 also promotes epithelial-mesenchymal transition (EMT) in many cancer types such as colon cancer, gastric cancer, pancreatic cancer, prostate cancer, liver cancer, and glioma by upregulating mesenchymal markers and downregulating epithelial markers.9 This evidence concerns the gene CD44 and malignant colon neoplasm.